Propanc Biopharma Registers Resale Of 6,500,000 Shares Of Common Stock

Benzinga Newsdesk www.benzinga.com Neutral 92.9%

Neg 0% Neu 92.9% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001517681/000149315226045770/forms-1.htm

Comments

No comments yet. Be the first!